PreveCeutical Medical Inc (18H) — Financial Flexibility Index
PreveCeutical Medical Inc (18H) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of €-520.46K (operating CF €-520.46K minus capex €0.00) represents 0% of total liabilities (€7.85 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PreveCeutical Medical Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for PreveCeutical Medical Inc across 9 annual periods. See PreveCeutical Medical Inc (18H) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for PreveCeutical Medical Inc (2016–2024)
Year-by-year free cash flow to debt coverage for PreveCeutical Medical Inc. For the full company profile including market capitalisation, see PreveCeutical Medical Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.06x | €-424.89K | €-426.69K | €6.86 Million | ▼ -24.3% |
| 2023 | -0.05x | €-296.97K | €-296.97K | €5.96 Million | ▲ +46.7% |
| 2022 | -0.09x | €-450.99K | €-450.99K | €4.82 Million | ▼ -7.4% |
| 2021 | -0.09x | €-371.19K | €-426.39K | €4.27 Million | ▼ -605.6% |
| 2020 | 0.02x | €67.25K | €64.59K | €3.91 Million | ▲ +109.3% |
| 2019 | -0.19x | €-992.61K | €-993.94K | €5.34 Million | ▲ +89.7% |
| 2018 | -1.81x | €-7.57 Million | €-7.57 Million | €4.19 Million | ▼ -28.7% |
| 2017 | -1.40x | €-4.13 Million | €-4.30 Million | €2.94 Million | ▲ +46.2% |
| 2016 | -2.61x | €-1.31 Million | €-1.32 Million | €503.24K | — |